PYC Share Price

Open 0.02 Change Price %
High 0.02 1 Day 0.00 0.00
Low 0.02 1 Week 0.00 0.00
Close 0.02 1 Month 0.00 0.00
Volume 1150000 1 Year 0.00 0.00
52 Week High 0.02
52 Week Low 0.01
PYC Important Levels
Resistance 2 0.02
Resistance 1 0.02
Pivot 0.02
Support 1 0.02
Support 2 0.02
ASX Australia Most Active Stocks
AGO 0.02 0.00%
AGO 0.02 0.00%
AGO 0.02 0.00%
GPP 0.03 0.00%
PDN 0.06 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
GMR 0.01 0.00%
GMR 0.01 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
RMG 0.02 100.00%
RMG 0.02 100.00%
GME 0.03 50.00%
GME 0.03 50.00%
GME 0.03 50.00%
GME 0.03 50.00%
RHT 0.03 50.00%
RHT 0.03 50.00%
BMN 0.03 50.00%
More..
ASX Australia Top Losers Stocks
HOG 0.00 -100.00%
HOG 0.00 -100.00%
PCL 0.00 -100.00%
PCL 0.00 -100.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
GTG 0.01 -50.00%
More..

Phylogica Ltd (ASX: PYC)

PYC Technical Analysis 2.5
As on 2nd Dec 2016 PYC Share Price closed @ 0.02 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.02 & Strong Sell for SHORT-TERM with Stoploss of 0.02 we also expect STOCK to react on Following IMPORTANT LEVELS.
PYC Target for December
1st Target up-side 0.02
2nd Target up-side 0.02
3rd Target up-side 0.02
1st Target down-side 0.02
2nd Target down-side 0.02
3rd Target down-side 0.02
PYC Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.phylogica.com.au
PYC Address
PYC
Telethon Institute for Child Health Research
100 Roberts Road
Subiaco, WA 6008
Australia
Phone: 61 8 9489 7777
Fax: 61 8 9489 7700
PYC Latest News
Average Directional Index Review for Phylogica Limited (PYC.AX)   StockTalk Daily   - 02nd Dec 16
Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic Helix ...   Business Wire (press release)   - 19th Oct 16
Acinetobacter Infections - Pipeline Review, H1 2016 - Review of 25 Companies ...   Business Wire (press release)   - 17th May 16
Reading the biotech tea leaves – part one   Finfeed (blog)   - 29th Jan 16
Phylogica has big six months ahead   Proactive Investors Australia   - 06th Oct 15
Roche buys GeneWeave to boost antibiotics portfolio   PMLiVE   - 14th Aug 15
biotechnology start-ups grapple with risk-shy market   ABC Online   - 15th Jul 15
Why Phylogica Limited soared 80% today   Motley Fool Australia   - 30th Mar 15
4 small biotech stocks for your watchlist   Motley Fool Australia   - 27th Oct 14
Pfizer ($PFE) signs separate agreements with Lpath, Phylogica   FierceBiotech   - 20th Dec 10
Interactive Technical Analysis Chart Phylogica Ltd ( PYC ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Phylogica Ltd
PYC Business Profile
Phylogica Limited provides drug discovery services utilizing Phylomer peptide libraries and screening methodologies to identify peptide drug candidates for its pharmaceutical and biotechnology partners in Australia. Its proprietary Phylomer libraries contain various peptides that represent a source of biologically active drug leads for a range of intracellular and extracellular disease targets; and Phylomer peptides are bioactive fragments of naturally occurring proteins, which are encoded in the genomes of evolutionary diverse microbes. The company’s Phylomer peptides include protein interactions that promote various diseases, such as infectious diseases, cancer, autoimmunity, and heart diseases. It has approximately 16 patent families comprising multiple granted/allowed patents in the United States and Australia, which cover methods of making the Phylomer libraries; methods of screening them and composition-of-matter claims for Phylomer libraries; and individual Phylomer peptides discovered for therapeutic and diagnostic applications. The company is based in Subiaco, Australia.